NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00654355,Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit,https://clinicaltrials.gov/study/NCT00654355,,COMPLETED,The purpose of this research study is to better understand how the study drug works when people use it to treat atopic dermatitis.,YES,Atopic Dermatitis,DRUG: tacrolimus ointment,"Adherence, adherence to topical therapy in children via MEMS cap in a ""real-life"" clinic population measured as the % of required applications completed, Week 4","The % Change From Baseline to Week 4 (or End of Treatment) in the IGA., Investigator Global Assessment: Investigator's Global Assessment of severity integrates all lesions for overall score. This measure is commonly used as a quick and simple way to quantify disease severity both for clinical studies and in a non-study clinic setting. Score ranges from '0' = clear or ""No inflammatory signs of AD"" to '4' = Very Severe Disease with ""severe erythema and severe papulation/infiltration with oozing/crusting."", Week 4|EASI, Eczema Area and Severity Index (EASI): Disease severity will be assessed by a physician with the Eczema Area and Severity Index (EASI). This measure is commonly used and well validated instrument of eczema severity. It is weighted for area in each of the four body regions (which differs for adults and children under 7) and scores erythema, excoriation, induration/papulation, and lichenification. The total scores range from 0-72. Higher scores represent more severe eczema., Week 4",,Wake Forest University,,ALL,CHILD,PHASE4,30,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,IRB00002300|contract #32417,2008-04,2009-09,2009-09,2008-04-08,2017-01-27,2018-08-01,"Dept of Dermatology, WFUHS, Winston-Salem, North Carolina, 27157, United States",
